The medical device industry is facing revenue and profitability challenges while operating in a highly regulated and competitive environment. Factors affecting revenue growth in the industry include increased competition, patent infringement and reduction in reimbursement rates. Profits are being challenged by increased clinical and regulatory standards, increased R & D expenses, increased materials and labor costs and increased cloud technology investment.
The pressures of innovation, coupled with the level of invested capital required of a manufacturer, create demands on the supply chain of a medical device company that must be directly, rather than implicitly, addressed in a transfer pricing strategy. Our unique in-house medical device expertise brings the depth and breadth that can deliver the “been-there; done-that” transfer pricing results you need while facilitating validation and integration at the C-suite level so that the tax department is poised to be integral to the future strategy of the business.